WO2011149006A1 - 容器入り水系組成物 - Google Patents
容器入り水系組成物 Download PDFInfo
- Publication number
- WO2011149006A1 WO2011149006A1 PCT/JP2011/062062 JP2011062062W WO2011149006A1 WO 2011149006 A1 WO2011149006 A1 WO 2011149006A1 JP 2011062062 W JP2011062062 W JP 2011062062W WO 2011149006 A1 WO2011149006 A1 WO 2011149006A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- water
- polyoxyethylene
- composition
- component
- group
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 113
- -1 alkali metal salt Chemical class 0.000 claims abstract description 201
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 121
- 230000005068 transpiration Effects 0.000 claims abstract description 100
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 69
- 229910001868 water Inorganic materials 0.000 claims abstract description 69
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 44
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 43
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims abstract description 42
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 23
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 23
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 22
- 229920003169 water-soluble polymer Polymers 0.000 claims abstract description 19
- 239000004359 castor oil Substances 0.000 claims description 40
- 235000019438 castor oil Nutrition 0.000 claims description 40
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 40
- 239000003112 inhibitor Substances 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 27
- 150000005215 alkyl ethers Chemical class 0.000 claims description 26
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 24
- 239000000194 fatty acid Substances 0.000 claims description 24
- 229930195729 fatty acid Natural products 0.000 claims description 24
- 239000008346 aqueous phase Substances 0.000 claims description 12
- 239000011734 sodium Substances 0.000 claims description 12
- 229920001577 copolymer Polymers 0.000 claims description 10
- 239000002537 cosmetic Substances 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 9
- 229910052751 metal Inorganic materials 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- 150000002739 metals Chemical class 0.000 claims description 7
- 239000012071 phase Substances 0.000 claims description 7
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 6
- 229920002125 Sokalan® Polymers 0.000 claims description 6
- 230000000737 periodic effect Effects 0.000 claims description 6
- 239000011591 potassium Substances 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 6
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 5
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 5
- 239000005977 Ethylene Substances 0.000 claims description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 150000005846 sugar alcohols Polymers 0.000 claims description 5
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 4
- 239000011777 magnesium Substances 0.000 claims description 4
- 229910052749 magnesium Inorganic materials 0.000 claims description 4
- 229920002401 polyacrylamide Polymers 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 229920001285 xanthan gum Polymers 0.000 claims description 4
- 235000010493 xanthan gum Nutrition 0.000 claims description 4
- 239000000230 xanthan gum Substances 0.000 claims description 4
- 229940082509 xanthan gum Drugs 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 229920001002 functional polymer Polymers 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract description 10
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract 1
- 230000001629 suppression Effects 0.000 description 21
- 230000005764 inhibitory process Effects 0.000 description 15
- 229920000642 polymer Polymers 0.000 description 13
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 10
- 235000002639 sodium chloride Nutrition 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229920006317 cationic polymer Polymers 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 229940075507 glyceryl monostearate Drugs 0.000 description 6
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 229960003975 potassium Drugs 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 230000002349 favourable effect Effects 0.000 description 4
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000002845 discoloration Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 3
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 3
- 239000001488 sodium phosphate Substances 0.000 description 3
- 238000007711 solidification Methods 0.000 description 3
- 230000008023 solidification Effects 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 3
- 229940117972 triolein Drugs 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- AMLFJZRZIOZGPW-NSCUHMNNSA-N (e)-prop-1-en-1-amine Chemical compound C\C=C\N AMLFJZRZIOZGPW-NSCUHMNNSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229920006318 anionic polymer Polymers 0.000 description 2
- 229940072107 ascorbate Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229920003086 cellulose ether Polymers 0.000 description 2
- 239000007859 condensation product Substances 0.000 description 2
- QLBHNVFOQLIYTH-UHFFFAOYSA-L dipotassium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [K+].[K+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O QLBHNVFOQLIYTH-UHFFFAOYSA-L 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 2
- 239000000347 magnesium hydroxide Substances 0.000 description 2
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 2
- 235000019799 monosodium phosphate Nutrition 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 239000000346 nonvolatile oil Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 235000011118 potassium hydroxide Nutrition 0.000 description 2
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- RPZANUYHRMRTTE-UHFFFAOYSA-N 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[3,4,5-tris(2-hydroxybutoxy)-6-[4,5,6-tris(2-hydroxybutoxy)-2-(2-hydroxybutoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]butan-2-ol Chemical compound COC1C(OC)C(OC)C(COC)OC1OC1C(OC)C(OC)C(OC)OC1COC.CCC(O)COC1C(OCC(O)CC)C(OCC(O)CC)C(COCC(O)CC)OC1OC1C(OCC(O)CC)C(OCC(O)CC)C(OCC(O)CC)OC1COCC(O)CC RPZANUYHRMRTTE-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- OQUFOZNPBIIJTN-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;sodium Chemical compound [Na].OC(=O)CC(O)(C(O)=O)CC(O)=O OQUFOZNPBIIJTN-UHFFFAOYSA-N 0.000 description 1
- ZKYCLDTVJCJYIB-UHFFFAOYSA-N 2-methylidenedecanamide Chemical compound CCCCCCCCC(=C)C(N)=O ZKYCLDTVJCJYIB-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical class O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- OVBJJZOQPCKUOR-UHFFFAOYSA-L EDTA disodium salt dihydrate Chemical compound O.O.[Na+].[Na+].[O-]C(=O)C[NH+](CC([O-])=O)CC[NH+](CC([O-])=O)CC([O-])=O OVBJJZOQPCKUOR-UHFFFAOYSA-L 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920000896 Ethulose Polymers 0.000 description 1
- 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004260 Potassium ascorbate Substances 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 1
- RXDLGFMMQFNVLI-UHFFFAOYSA-N [Na].[Na].[Ca] Chemical compound [Na].[Na].[Ca] RXDLGFMMQFNVLI-UHFFFAOYSA-N 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- CNYFJCCVJNARLE-UHFFFAOYSA-L calcium;2-sulfanylacetic acid;2-sulfidoacetate Chemical compound [Ca+2].[O-]C(=O)CS.[O-]C(=O)CS CNYFJCCVJNARLE-UHFFFAOYSA-L 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- WDRWZVWLVBXVOI-QTNFYWBSSA-L dipotassium;(2s)-2-aminopentanedioate Chemical compound [K+].[K+].[O-]C(=O)[C@@H](N)CCC([O-])=O WDRWZVWLVBXVOI-QTNFYWBSSA-L 0.000 description 1
- ZLSFWAPBBIIMKI-KVINTPOGSA-M dipotassium;(2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-2,4a,6a,6b,9,9,12a-heptamethyl-10-oxido-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound [K+].[K+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H]([O-])C1(C)C ZLSFWAPBBIIMKI-KVINTPOGSA-M 0.000 description 1
- UZLGHNUASUZUOR-UHFFFAOYSA-L dipotassium;3-carboxy-3-hydroxypentanedioate Chemical compound [K+].[K+].OC(=O)CC(O)(C([O-])=O)CC([O-])=O UZLGHNUASUZUOR-UHFFFAOYSA-L 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- CVOQYKPWIVSMDC-UHFFFAOYSA-L dipotassium;butanedioate Chemical compound [K+].[K+].[O-]C(=O)CCC([O-])=O CVOQYKPWIVSMDC-UHFFFAOYSA-L 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 235000019262 disodium citrate Nutrition 0.000 description 1
- 239000002526 disodium citrate Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 229920013818 hydroxypropyl guar gum Polymers 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- ZHALCRSGRSWRHV-UHFFFAOYSA-L magnesium;2-sulfanylacetate Chemical compound [Mg+2].[O-]C(=O)CS.[O-]C(=O)CS ZHALCRSGRSWRHV-UHFFFAOYSA-L 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000013919 monopotassium glutamate Nutrition 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000011970 polystyrene sulfonate Substances 0.000 description 1
- 229960002796 polystyrene sulfonate Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 235000010408 potassium alginate Nutrition 0.000 description 1
- 239000000737 potassium alginate Substances 0.000 description 1
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 description 1
- 235000019275 potassium ascorbate Nutrition 0.000 description 1
- 229940017794 potassium ascorbate Drugs 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- DJEHXEMURTVAOE-UHFFFAOYSA-M potassium bisulfite Chemical compound [K+].OS([O-])=O DJEHXEMURTVAOE-UHFFFAOYSA-M 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229940093956 potassium carbonate Drugs 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 235000010259 potassium hydrogen sulphite Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 229940093932 potassium hydroxide Drugs 0.000 description 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- 229940099402 potassium metaphosphate Drugs 0.000 description 1
- 235000019828 potassium polyphosphate Nutrition 0.000 description 1
- 229910052913 potassium silicate Inorganic materials 0.000 description 1
- 235000019353 potassium silicate Nutrition 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- CONVKSGEGAVTMB-RXSVEWSESA-M potassium-L-ascorbate Chemical compound [K+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] CONVKSGEGAVTMB-RXSVEWSESA-M 0.000 description 1
- PWEZHTCCMJFGJY-IHMBCTQLSA-M potassium;(2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound [K+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C PWEZHTCCMJFGJY-IHMBCTQLSA-M 0.000 description 1
- CYTMSUFQXVURGG-UHFFFAOYSA-N potassium;3-acetyl-6-methylpyran-3-ide-2,4-dione Chemical compound [K+].CC(=O)[C-]1C(=O)C=C(C)OC1=O CYTMSUFQXVURGG-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229940001593 sodium carbonate Drugs 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 235000019795 sodium metasilicate Nutrition 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- WRZYGPIFICWRCG-OOFFSTKBSA-M sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trih Chemical compound [Na+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O WRZYGPIFICWRCG-OOFFSTKBSA-M 0.000 description 1
- 235000011078 sorbitan tristearate Nutrition 0.000 description 1
- 239000001589 sorbitan tristearate Substances 0.000 description 1
- 229960004129 sorbitan tristearate Drugs 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- MWJAPUXMVCFSRO-UHFFFAOYSA-J tetrapotassium 1,2-diphosphonatoethanol Chemical compound [K+].[K+].[K+].[K+].[O-]P(=O)([O-])C(O)CP([O-])([O-])=O MWJAPUXMVCFSRO-UHFFFAOYSA-J 0.000 description 1
- JZBRFIUYUGTUGG-UHFFFAOYSA-J tetrapotassium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [K+].[K+].[K+].[K+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O JZBRFIUYUGTUGG-UHFFFAOYSA-J 0.000 description 1
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 1
- NZSVKAITUCOVRM-UHFFFAOYSA-J tetrasodium 1,2-diphosphonatoethanol Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P(=O)([O-])C(O)CP([O-])([O-])=O NZSVKAITUCOVRM-UHFFFAOYSA-J 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- FYZXEMANQYHCFX-UHFFFAOYSA-K tripotassium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxymethyl)amino]acetate Chemical compound [K+].[K+].[K+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O FYZXEMANQYHCFX-UHFFFAOYSA-K 0.000 description 1
- 229960005066 trisodium edetate Drugs 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K3/00—Materials not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
Definitions
- the present invention relates to an aqueous composition with good stability in which moisture transpiration is suppressed from an aqueous phase.
- compositions containing water as a base there are many compositions containing water as a base, and such aqueous compositions prevent water from evaporating from the composition. Therefore, in many cases, the composition is stored in a closed container. However, when the lid is opened daily, the water gradually evaporates from the aqueous composition, which may cause changes in physical properties or discoloration.
- spray-type containers, pump-type containers, etc. the discharged contents remain at the discharge port and dry near the discharge port, so the contents attached to the discharge port cause discoloration and odor, There was a problem of worsening the feeling of use. Further, the contents are dried and solidified, resulting in clogging, and in some cases, there is a problem that ejection is impossible.
- a non-volatile liquid oil is used for at least one selected from solid substances and / or film-forming polymers at 25 ° C. or lower. It has been proposed to blend at a specific ratio (see Patent Document 1). However, in order to suppress the solidification of the contents, it is necessary to add a large amount of non-volatile oil agent, and the dosage form is limited. Moreover, even if it mix
- JP 2003-332121 A JP-A-1-266844 Japanese National Patent Publication No. 11-508253
- the present invention includes the following components (A) to (D): (A) Polyoxyethylene alkyl or alkenyl ether in which the alkyl group or alkenyl group has 20 to 24 carbon atoms and the average added mole number of ethylene oxide is 1.5 to 4 (B) Water-soluble polymer (C) Ethylene A nonionic surfactant having an oxide group (excluding the component (A)) (D) An aqueous composition containing a container containing water is provided.
- the present invention also includes the following components (A) to (C):
- (C) Ethylene An object of the present invention is to provide a moisture transpiration inhibitor from an aqueous composition containing a nonionic surfactant having an oxide group (excluding the component (A)) as an active ingredient.
- the present invention relates to a polyoxyethylene alkyl or alkenyl ether in which (A) the alkyl group or alkenyl group has 20 to 24 carbon atoms and the average added mole number of ethylene oxide is 1.5 to 4 in the aqueous composition. (B) a water-soluble polymer, and (C) a nonionic surfactant having an ethylene oxide group (however, excluding component (A)), a method for inhibiting moisture transpiration from an aqueous composition Is to provide.
- the present inventor suppresses the transpiration of the water-based composition in the container to suppress the solidification and property change of the contents, has excellent stability over time, and even when used in a spray-type container or a pump-type container.
- a combination of a water-soluble polymer and polyoxyethylene alkyl or alkenyl ether When used, water evaporation from the aqueous composition can be remarkably suppressed, and the effect thereof is that polyoxyethylene alkyl or alkenyl ether has an alkyl group or an alkenyl group having 20 to 24 carbon atoms, and an average addition mole of ethylene oxide.
- the object of the present invention is to maintain an excellent moisture transpiration suppression effect and to maintain a stable aging stability even when an alkali metal salt or the like is blended in the container-containing aqueous composition. It is to provide.
- the present inventor has added a nonionic surfactant having an ethylene oxide group in addition to the water-soluble polymer and the polyoxyethylene alkyl or alkenyl ether to the aqueous composition.
- a nonionic surfactant having an ethylene oxide group in addition to the water-soluble polymer and the polyoxyethylene alkyl or alkenyl ether to the aqueous composition.
- the present invention has a high water transpiration control effect even when a water transpiration inhibitor such as an alkali metal salt is blended, and is capable of suppressing changes in appearance such as separation even when stored for a long period of time.
- An aqueous composition excellent in water resistance is provided.
- the addition of a small amount of the component (A) (hereinafter sometimes referred to as polyoxyethylene alkyl ether (A) or POE alkyl ether) or a nonionic surfactant having an ethylene oxide group produces a high moisture transpiration suppressing effect. Since it is maintained, there is no limitation on the dosage form, and the feeling of use is not affected.
- composition of the present invention are as follows, for example.
- aqueous composition (A) a polyoxyethylene alkyl or alkenyl ether in which the alkyl group or alkenyl group has 20 to 24 carbon atoms and the average added mole number of ethylene oxide is 1.5 to 4;
- a method for suppressing moisture transpiration from an aqueous composition comprising B) a water-soluble polymer, and (C) a nonionic surfactant having an ethylene oxide group (excluding the component (A)).
- Component (A) is a polyoxyethylene alkyl or alkenyl ether having an alkyl group or alkenyl group having 20 to 24 carbon atoms and an average addition mole number of ethylene oxide of 1.5 to 2.5 [1]
- the component (A) is polyoxyethylene (2) aralkyl ether, polyoxyethylene (3) aralkyl ether, polyoxyethylene (4) aralkyl ether, polyoxyethylene (2) behenyl ether, polyoxyethylene (3 ) Behenyl ether, polyoxyethylene (4) behenyl ether, polyoxyethylene (2) carnerville ether, polyoxyethylene (3) carnerville ether and polyoxyethylene (4) carnerville ether [1 ],
- the water-based composition in a container according to any one of [4] and [5] the moisture transpiration inhibitor according to any one of [2], [4] and [5], or [3] and [4] [5]
- Component (A) is a polyoxyethylene alkyl or alkenyl ether having an alkyl group or alkenyl group having 21 to 23 carbon atoms and an average addition mole number of ethylene oxide of 1.5 to 4 [1], [4 ]
- To the water-based composition in a container according to any one of [6], [2], the moisture transpiration inhibitor according to any one of [4] to [6], or [3], [4] to [6] The method for suppressing moisture transpiration according to any one of the above.
- Component (A) is a polyoxyethylene alkyl or alkenyl ether having an alkyl group or alkenyl group having 21 to 23 carbon atoms and an average addition mole number of ethylene oxide of 1.5 to 3, [1], [4 ]
- To the water-based composition in a container according to any one of [7] to [7], the moisture transpiration inhibitor according to any one of [2] and [4] to [7], or [3], [4] to [7] The method for suppressing moisture transpiration according to any one of the above.
- Component (A) is a polyoxyethylene alkyl or alkenyl ether having an alkyl group or alkenyl group having 21 to 23 carbon atoms and an average addition mole number of ethylene oxide of 1.5 to 2.5 [1], [4] to [8]
- the water-based composition in a container according to any one of the above, [2], the moisture transpiration inhibitor according to any one of [4] to [8], or [3], [4] to [4] [8] The method for suppressing moisture transpiration according to any one of [8].
- [10] The water-based composition in a container according to any one of [1], [4] to [9], wherein the component (A) is polyoxyethylene (2) behenyl ether, [2], [4] to [4]
- [11] The aqueous composition in a container according to any one of [1], [4] to [10], containing 0.05 to 20% by mass of the component (A) based on the total amount of the composition, [2],
- [12] The water-based composition in a container according to any one of [1] and [4] to [11], containing 0.1 to 20% by mass of the component (A) based on the total amount of the composition, [2], The moisture transpiration inhibitor according to any one of [4] to [11] or the moisture transpiration inhibition method according to any of [3] and [4] to [11].
- [13] The water-based composition in a container according to any one of [1] and [4] to [12], containing 0.1 to 10% by mass of the component (A) based on the total amount of the composition, [2], The moisture transpiration inhibitor according to any one of [4] to [12] or the moisture transpiration inhibition method according to any of [3] and [4] to [12].
- Component (B) is selected from the group consisting of carboxyvinyl polymer, acrylic acid / alkyl methacrylate copolymer, xanthan gum, hydroxypropyl methylcellulose, polyacrylamide and (Na acrylate / acryloyl dimethyl taurine Na) copolymer.
- [15] The aqueous composition in a container according to any one of [1] and [4] to [14], which contains 0.01 to 5% by mass of the component (B) with respect to the total amount of the composition, [2], The moisture transpiration inhibitor according to any one of [4] to [14] or the moisture transpiration inhibition method according to any of [3] and [4] to [14].
- [16] The container-containing aqueous composition according to any one of [1] and [4] to [15], containing 0.05 to 3% by mass of the component (B) based on the total amount of the composition, [2], The moisture transpiration inhibitor according to any one of [4] to [15] or the moisture transpiration inhibition method according to any of [3] and [4] to [15].
- Component (C) is polyoxyethylene alkyl ether, polyoxyethylene alkylphenyl ether, polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester [1], [4] to [18], one or more selected from polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyalkylene hydrogenated castor oil fatty acid ester and polyoxyethylene sorbitol
- component (C) selected from polyoxyethylene glycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil and polyoxyalkylene hydrogenated castor oil fatty acid ester
- component (C) selected from polyoxyethylene glycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil and polyoxyalkylene hydrogenated castor oil fatty acid ester
- [21] The water-based composition in a container according to any one of [1] and [4] to [20], which contains 0.001 to 15% by mass of the component (C) with respect to the total amount of the composition, [2], The moisture transpiration inhibitor according to any one of [4] to [20], or the moisture transpiration inhibition method according to any one of [3] and [4] to [20].
- [22] The aqueous composition in a container according to any one of [1] and [4] to [21], containing 0.005 to 10% by mass of the component (C) based on the total amount of the composition, [2], The moisture transpiration inhibitor according to any one of [4] to [21] or the moisture transpiration inhibition method according to any of [3] and [4] to [21].
- the water-containing composition in a container according to any one of [2] and [4] to [24] or the moisture transpiration inhibitor according to any one of [3] and [4] to [24].
- the aqueous composition in the present invention is a composition in which the aqueous phase is a continuous phase, an aqueous solution composition containing a water-soluble component, an oil-in-water emulsion composition containing water in the continuous phase, and W / O / W type.
- the emulsified composition is included.
- the aqueous phase in the present invention is a phase containing water.
- the water transpiration suppression inhibitor in the present invention is a substance that significantly increases the water transpiration rate when added to an aqueous composition containing polyoxyethylene alkyl ether (A), a water-soluble polymer, and water.
- A polyoxyethylene alkyl ether
- the moisture transpiration rate of the composition of Table 1 is 10 mg / h or more with respect to the moisture transpiration rate of the composition of Table 1 to which no test substance is added. If it is a substance that rises, it can be said to be a substance that inhibits moisture transpiration in the present invention.
- periodic table group 1 metal alkali metal
- periodic table group 2 metal periodic table group 2 metal
- water-soluble compounds of these metals an aqueous composition containing polyoxyethylene alkyl ether (A) and a water-soluble polymer is used. By adding, a phenomenon that the water transpiration suppressing effect is remarkably reduced is observed.
- the content of these moisture transpiration inhibition inhibitors in the aqueous composition is not particularly limited, but considering various medicinal effects and actions, it may be contained in an amount of 0.0001% by mass or more, preferably 0.0001 to 10% by mass. If contained, sufficient various medicinal effects and actions can be obtained.
- the alkyl group or alkenyl group has 20 to 24 carbon atoms, and the average added mole number of ethylene oxide is 1.5 to 4.
- the alkyl group or alkenyl group of the polyoxyethylene alkyl ether (A) may be linear or branched and may be of any structure, but is preferably a linear or branched alkyl group, more preferably a linear chain. It is an alkyl group.
- the alkyl group or alkenyl group has 20 to 24 carbon atoms, preferably 21 to 23 carbon atoms, and most preferably a behenyl group having 22 carbon atoms.
- the alkyl group or alkenyl group has less than 20 carbon atoms, the effect of suppressing moisture transpiration is low, which is not preferable.
- the number of carbon atoms of the alkyl group or alkenyl group exceeds 24, it is difficult to dissolve in the aqueous phase, which is not preferable in the preparation.
- the average added mole number of ethylene oxide of the polyoxyethylene alkyl ether (A) is in the range of 1.5 to 4, preferably 1.5 to 3, and more preferably 1.5 to 2.5.
- the average number of added moles is less than 1.5, the crystallinity is high and it is difficult to dissolve in the aqueous phase, which is not preferable.
- the average added mole number exceeds 4, the effect of suppressing moisture transpiration is remarkably reduced, which is not preferable.
- the generally available polyoxyethylene alkyl ether (A) is a mixture having a very wide distribution centering on a desired degree of polymerization with respect to the number of moles of ethylene oxide added, but the average number of moles added is within the above range. This is important in the present invention.
- polyoxyethylene alkyl ether (A) of the present invention mainly polyoxyethylene (2) aralkyl ether, polyoxyethylene (3) aralkyl ether, polyoxyethylene (4) aralkyl ether, polyoxyethylene (2) behenyl ether, Polyoxyethylene (3) behenyl ether, polyoxyethylene (4) behenyl ether, polyoxyethylene (2) carnerville ether, polyoxyethylene (3) carnerville ether, polyoxyethylene (4) carnerville ether, etc.
- Preferred examples include polyoxyethylene (2) behenyl ether, polyoxyethylene (3) behenyl ether, and polyoxyethylene (4) behenyl ether.
- the average added mole number of the polyoxyethylene alkyl ether used is in the above range, it is possible to use other than the polyoxyethylene alkyl ethers exemplified above.
- the content of the polyoxyethylene alkyl ether (A) in the aqueous composition of the present invention is preferably 0.05 to 20% by mass, more preferably 0.1 to 20% by mass, based on the total amount of the composition. More preferably, the content is 0.1 to 10% by mass. If it is in the said range, the moisture transpiration suppression effect is high, and it can mix
- a water-soluble polymer is used in the aqueous composition of the present invention.
- the water-soluble polymer stably disperses and holds the polyoxyethylene alkyl ether (A) in the aqueous phase, and contributes to the moisture transpiration suppression effect.
- Examples of the water-soluble polymer used in the present invention include a water-soluble cationic polymer, an anionic polymer, a nonionic polymer, and an amphoteric polymer or a bipolar polymer.
- the cationic polymer examples include poly (dimethyldiallylammonium halide) type cationic polymer, dimethyldiallylammonium halide and acrylamide copolymer cationic polymer, quaternary nitrogen-containing cellulose ether, or polyethylene glycol.
- poly (dimethyldiallylammonium halide) type cationic polymer dimethyldiallylammonium halide and acrylamide copolymer cationic polymer, quaternary nitrogen-containing cellulose ether, or polyethylene glycol.
- the poly (dimethyldiallylammonium halide) type cationic polymer is a marcoat. Examples include those sold by Merck & Co. Inc.
- Examples of the copolymer-type cationic polymer of dimethyldiallylammonium halide and acrylamide include Merquat 550 (Merquat & Co., Inc.).
- Examples of condensation products of polyethylene glycol, epichlorohydrin, propyleneamine and taroylamine or cocoylamine are those sold by Henkel International Co. under the trade name of Polyquat H (Polyquat H). Can be mentioned.
- the quaternary nitrogen-containing cellulose is a product name of polymer JR-400 (Polymer JR-400), polymer JR-125 (Polymer JR-125), polymer JR-30M (Polymer JR-30M), and US Union Carbite Corporation ( For example, those sold by Union Carbide Corp.).
- the cationized vinylpyrrolidone / dimethylaminoethyl methacrylate copolymer is commercially available from GAF Corp. in the United States under the trade names Guffcoat 755 and Gafquat 734.
- anionic polymer examples include carboxyvinyl polymer, carboxymethyl cellulose, carrageenan, xanthan gum, polystyrene sulfonate, agar, gatch gum, caraya gum, pectin, alginate salt, poly (acrylic acid), acrylic acid, and methacrylic acid.
- acrylic and methacrylic acid derivatives such as alkali metals and ammonium salts.
- nonionic polymers include cellulose ethers (hydroxybutylmethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, ethylhydroxyethylcellulose, hydroxyethylcellulose, etc.), propylene glycol alginate, polyacrylamide, (Na acrylate) / Acryloyldimethyltaurine Na) copolymer, poly (ethylene oxide), polyvinyl alcohol, polyvinylpyrrolidone, hydroxypropyl guar gum, locust bean gum, amylose, hydroxyethyl amylose, hyaluronic acid and its alkali metal salts, starch and starch derivatives and mixtures thereof Etc.
- cellulose ethers hydroxybutylmethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, ethylhydroxyethylcellulose, hydroxyethylcellulose, etc.
- propylene glycol alginate polyacrylamide, (Na acrylate) / Ac
- amphoteric polymer or the bipolar polymer include octylacrylamide / acrylate / butylaminoethyl methacrylate copolymer, polyquaternium-47, and polyquaternium-43.
- water-soluble polymers can be used alone or in combination of two or more.
- the content of the water-soluble polymer used in the present invention is preferably from 0.01 to 5% by mass, more preferably from 0.05 to 3% by mass, based on the total amount of the composition. If it is in the said range, stability of a formulation will be maintained and the outstanding moisture transpiration suppression effect will be acquired and it is preferable.
- the nonionic surfactant (excluding polyoxyethylene alkyl ether (A)) having an ethylene oxide group used in the present invention includes an ether type and an ester type, and the ether type includes a polyoxy Ethylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene polyoxypropylene alkyl ether, ester types include polyoxyethylene fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene castor oil And polyoxyethylene hydrogenated castor oil, polyoxyalkylene hydrogenated castor oil fatty acid ester, and polyoxyethylene sorbitol.
- the ether type includes a polyoxy Ethylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene polyoxypropylene alkyl ether, ester types include polyoxyethylene fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene sorbitan
- ester type is preferable from the viewpoint of usability and safety, and polyoxyethylene glycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyalkylene cured Castor oil fatty acid ester is preferred.
- the average addition mole number of ethylene oxide of the nonionic surfactant having an ethylene oxide group is preferably 10 or more, more preferably 10 to 200, still more preferably 20 to 200, still more preferably 30 to 140, and still more preferably 40. ⁇ 120. Within this range, skin irritation is low, an excellent effect of suppressing moisture transpiration is obtained, and stability over time is also high, which is preferable.
- Preferred nonionic surfactants having an ethylene oxide group include, for example, polyoxyethylene (40) glyceryl trioleate, polyoxyethylene (50) glyceryl trioleate, polyoxyethylene (60) glyceryl trioleate, polyoxyethylene ( 45) Glyceryl monostearate, polyoxyethylene (50) glyceryl monostearate, polyoxyethylene (75) glyceryl monostearate, polyoxyethylene (90) glyceryl monostearate, polyoxyethylene (100) glyceryl monostearate , Polyoxyethylene (120) glyceryl monostearate, polyoxyethylene (40) glyceryl monoisostearate, polyoxyethylene (40) glyceryl triisostearate Polyoxyethylene (50) glyceryl triisostearate, polyoxyethylene (60) glyceryl triisostearate, polyoxyethylene (120) sorbitan tristearate, polyoxyethylene (40) castor oil, polyoxyethylene
- the content of the (C) nonionic surfactant having an ethylene oxide group used in the present invention is preferably 0.001 to 15% by mass, more preferably 0.005 to 10% by mass, based on the total amount of the composition. More preferably, the content is 0.01 to 5% by mass. If it is in the said range, skin irritation is low, and the favorable moisture evaporation suppression effect is acquired and it is preferable.
- the content ratio by mass of the nonionic surfactant having an ethylene oxide group and the moisture transpiration inhibitor is preferably 1:20 to 50: 1, more preferably 1:12 to 20: 1, still more preferably 1: 4 to 15: 1. If it is in the said range, the favorable moisture transpiration suppression effect will be acquired and it is preferable.
- polyhydric alcohol in order to increase the solubility of the polyoxyethylene alkyl ether (A) in the aqueous phase.
- Preferred polyhydric alcohols include ethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol (average molecular weight less than 1000), propylene glycol, dipropylene glycol, polypropylene glycol (average molecular weight: less than 1000), isoprene glycol, and 1,3-butylene.
- glycols such as glycol; glycerin, diglycerin, polyglycerin and the like.
- the polyhydric alcohol content is preferably 0.5 to 50 times, more preferably 1 to 35 times, and even more preferably 1 to 20 times in terms of mass ratio with respect to the content of polyoxyethylene alkyl ether (A). . If it is in the said range, the solubility of polyoxyethylene alkyl ether (A) will be favorable, and the favorable moisture evaporation suppression effect will be acquired and it is preferable.
- composition of the present invention in addition to the essential components described above, higher alcohols, fatty acids, esters, sterols, sterol fatty acid esters, hydrocarbons, fats and oils, as long as the object of the present invention is not impaired.
- the amount of water in the aqueous composition of the present invention is not limited as long as the aqueous solution or the continuous phase can form an O / W-based or W / O / W-based emulsified system in the aqueous phase, and is preferably 10% by mass or more. 15 mass% or more is more preferable, and 20 mass% or more is especially preferable. As long as the stability of the preparation is maintained, the aqueous composition of the present invention can obtain a high moisture transpiration suppressing effect even in a low-viscosity liquid having a viscosity (25 ° C.) of 100 mPa ⁇ s or less.
- the dosage form of the aqueous composition of the present invention is not particularly limited as long as the aqueous phase is a continuous phase, and can be an emulsion, gel, spray, mousse or the like.
- aqueous composition of the present invention is not particularly limited, and suitable examples include cosmetics, pharmaceuticals, quasi drugs, foods (including health foods), and the like. Specifically, it can be suitably used as skin cosmetics such as hair cosmetics such as shampoos, rinses and conditioners, facial cleansers, cleansing cosmetics, sunscreen cosmetics, packs, and massage cosmetics.
- skin cosmetics such as hair cosmetics such as shampoos, rinses and conditioners, facial cleansers, cleansing cosmetics, sunscreen cosmetics, packs, and massage cosmetics.
- the container used in the present invention is a container having a certain degree of hermeticity, such as a bottle with a lid, a jar bottle, a tube, a spray container, a pump-type container, a pump-type former container, etc. If it is, it will not be restrict
- These containers can be used by being filled with the aqueous composition.
- aqueous composition of the present invention when used in a discharge container such as a spray container, a pump-type container, or a pump-type former container, even if it contains solid lipids or powders that are easily solidified, it is altered at the discharge port (discoloration). , Foul odor) and clogging can be prevented, and can be suitably used.
- the present invention will be described more specifically with reference to examples and comparative examples, but the present invention is not limited to the following examples.
- the quantity of each component is mass%.
- polyoxyethylene behenyl ether having an average addition mole number of 5 is superior to other polyoxyethylene alkyl ethers, especially polyoxyethylene behenyl ether having an average addition mole number of 1.5 to 4, especially 2. It can be seen that it exhibits high water transpiration.
- Test 2 Water transpiration suppression effect The water transpiration rate was measured in the same manner as in Test 1 for Examples 1 to 5, Comparative Examples 1 to 7 and the controls shown in Tables 4 and 5 below. Moreover, the moisture evaporation suppression rate with respect to control (control of Table 5) was defined as follows.
- Moisture transpiration inhibition rate (%) ⁇ 1- (water transpiration rate in Examples or Comparative Examples) / (water transpiration rate in control) ⁇ ⁇ 100
- Test 2 shows that the combined use of polyoxyethylene alkyl ether (A) and water-soluble polymer (Comparative Example 7) suppresses moisture transpiration (41 mg / h) compared to control (122 mg / h).
- A polyoxyethylene alkyl ether
- Comparative Example 7 suppresses moisture transpiration (41 mg / h) compared to control (122 mg / h).
- an alkali metal salt or the like the moisture transpiration suppressing effect is reduced (Comparative Examples 1 to 6).
- a nonionic surfactant having an ethylene oxide group the reduction of the water transpiration suppression effect by the water transpiration suppression inhibitor can be improved to a level not containing the water transpiration suppression inhibitor. I understand.
- Test 3 Concentration dependence of water transpiration control effect of nonionic surfactant having an ethylene oxide group
- Examples 6 to 11 and Comparative Examples 8 and 9 shown in Table 6 below are the same as in Tests 1 and 2.
- the weight change of the sample was measured, and the moisture transpiration rate and the moisture transpiration suppression rate were determined.
- POE hydrogenated castor oil having an ethylene oxide group has an increased water transpiration control effect with about one-tenth of the amount of potassium glycyrrhizinate, which is a water transpiration suppression inhibitor, and about one fifth. It can be seen that the blending amount is improved to a level not containing the moisture transpiration inhibitor.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
(A)アルキル基又はアルケニル基の炭素数が20~24で、エチレンオキサイドの平均付加モル数が1.5~4であるポリオキシエチレンアルキル又はアルケニルエーテル
(B)水溶性高分子
(C)エチレンオキサイド基を有するノニオン性界面活性剤(但し、(A)成分は除く)(D)水
を含有する容器入り水系組成物を提供するものである。
(A)アルキル基又はアルケニル基の炭素数が20~24で、エチレンオキサイドの平均付加モル数が1.5~4であるポリオキシエチレンアルキル又はアルケニルエーテル
(B)水溶性高分子
(C)エチレンオキサイド基を有するノニオン性界面活性剤(但し、(A)成分は除く)を有効成分とする水系組成物からの水分蒸散抑制剤を提供するものである。
ところが、斯かる水系組成物を化粧料や医薬部外品、医薬品等に応用すべく、種々の生理作用や薬理作用等を有する水溶性成分の配合を検討し、種々のアルカリ金属塩等を配合したところ、前記水分蒸散抑制効果が著しく低下してしまうという問題が生じることが判明した。
従って、本発明の課題は、アルカリ金属塩等を前記容器入り水系組成物に配合した場合であっても、優れた水分蒸散抑制効果を維持し、経時安定性に優れた容器入り水系組成物を提供することにある。
[1]次の成分(A)~(D):
(A)アルキル基又はアルケニル基の炭素数が20~24で、エチレンオキサイドの平均付加モル数が1.5~4であるポリオキシエチレンアルキル又はアルケニルエーテル、
(B)水溶性高分子、
(C)エチレンオキサイド基を有するノニオン性界面活性剤(但し、(A)成分は除く)
(D)水
を含有する容器入り水系組成物。
[2]次の成分(A)~(C):
(A)アルキル基又はアルケニル基の炭素数が20~24で、エチレンオキサイドの平均付加モル数が1.5~4であるポリオキシエチレンアルキル又はアルケニルエーテル、
(B)水溶性高分子
(C)エチレンオキサイド基を有するノニオン性界面活性剤(但し、(A)成分は除く)
を有効成分とする水系組成物からの水分蒸散抑制剤。
[3]水系組成物中に、(A)アルキル基又はアルケニル基の炭素数が20~24で、エチレンオキサイドの平均付加モル数が1.5~4であるポリオキシエチレンアルキル又はアルケニルエーテル、(B)水溶性高分子、及び(C)エチレンオキサイド基を有するノニオン性界面活性剤(但し、(A)成分は除く)を含有させることを特徴とする水系組成物からの水分蒸散抑制方法。
[4]成分(A)が、アルキル基又はアルケニル基の炭素数が20~24でエチレンオキサイドの平均付加モル数1.5~3のポリオキシエチレンアルキル又はアルケニルエーテルである[1]記載の容器入り水系組成物、[2]記載の水分蒸散抑制剤又は[3]記載の水分蒸散抑制方法。
[5]成分(A)が、アルキル基又はアルケニル基の炭素数が20~24で、エチレンオキサイドの平均付加モル数1.5~2.5のポリオキシエチレンアルキル又はアルケニルエーテルである[1]若しくは[4]記載の容器入り水系組成物、[2]若しくは[4]記載の水分蒸散抑制剤又は[3]若しくは[4]記載の水分蒸散抑制方法。
[6]成分(A)が、ポリオキシエチレン(2)アラキルエーテル、ポリオキシエチレン(3)アラキルエーテル、ポリオキシエチレン(4)アラキルエーテル、ポリオキシエチレン(2)ベヘニルエーテル、ポリオキシエチレン(3)ベヘニルエーテル、ポリオキシエチレン(4)ベヘニルエーテル、ポリオキシエチレン(2)カルナービルエーテル、ポリオキシエチレン(3)カルナービルエーテル及びポリオキシエチレン(4)カルナービルエーテルから選ばれるものである[1]、[4]、[5]のいずれかに記載の容器入り水系組成物、[2]、[4]、[5]のいずれかに記載の水分蒸散抑制剤又は[3]、[4]、[5]のいずれかに記載の水分蒸散抑制方法。
[7]成分(A)が、アルキル基又はアルケニル基の炭素数が21~23でエチレンオキサイドの平均付加モル数1.5~4のポリオキシエチレンアルキル又はアルケニルエーテルである[1]、[4]~[6]のいずれかに記載の容器入り水系組成物、[2]、[4]~[6]のいずれかに記載の水分蒸散抑制剤又は[3]、[4]~[6]のいずれかに記載の水分蒸散抑制方法。
[8]成分(A)が、アルキル基又はアルケニル基の炭素数が21~23でエチレンオキサイドの平均付加モル数1.5~3のポリオキシエチレンアルキル又はアルケニルエーテルである[1]、[4]~[7]のいずれかに記載の容器入り水系組成物、[2]、[4]~[7]のいずれかに記載の水分蒸散抑制剤又は[3]、[4]~[7]のいずれかに記載の水分蒸散抑制方法。
[9]成分(A)が、アルキル基又はアルケニル基の炭素数が21~23でエチレンオキサイドの平均付加モル数1.5~2.5のポリオキシエチレンアルキル又はアルケニルエーテルである[1]、[4]~[8]のいずれかに記載の容器入り水系組成物、[2]、[4]~[8]のいずれかに記載の水分蒸散抑制剤又は[3]、[4]~[8]のいずれかに記載の水分蒸散抑制方法。
[10]成分(A)が、ポリオキシエチレン(2)ベヘニルエーテルである[1]、[4]~[9]のいずれかに記載の容器入り水系組成物、[2]、[4]~[9]のいずれかに記載の水分蒸散抑制剤又は[3]、[4]~[9]のいずれかに記載の水分蒸散抑制方法。
[11]成分(A)を組成物全量に対して0.05~20質量%含有する[1]、[4]~[10]のいずれかに記載の容器入り水系組成物、[2]、[4]~[10]のいずれかに記載の水分蒸散抑制剤又は[3]、[4]~[10]のいずれかに記載の水分蒸散抑制方法。
[12]成分(A)を組成物全量に対して0.1~20質量%含有する[1]、[4]~[11]のいずれかに記載の容器入り水系組成物、[2]、[4]~[11]のいずれかに記載の水分蒸散抑制剤又は[3]、[4]~[11]のいずれかに記載の水分蒸散抑制方法。
[13]成分(A)を組成物全量に対して0.1~10質量%含有する[1]、[4]~[12]のいずれかに記載の容器入り水系組成物、[2]、[4]~[12]のいずれかに記載の水分蒸散抑制剤又は[3]、[4]~[12]のいずれかに記載の水分蒸散抑制方法。
[14]成分(B)が、カルボキシビニルポリマー、アクリル酸・メタクリル酸アルキル共重合体、キサンタンガム、ヒドロキシプロピルメチルセルロース、ポリアクリルアミド及び(アクリル酸Na/アクリロイルジメチルタウリンNa)コポリマーからなる群から選択される1種又は2種以上である[1]、[4]~[13]のいずれかに記載の容器入り水系組成物、[2]、[4]~[13]のいずれかに記載の水分蒸散抑制剤又は[3]、[4]~[13]のいずれかに記載の水分蒸散抑制方法。
[15]成分(B)を組成物全量に対して0.01~5質量%含有する[1]、[4]~[14]のいずれかに記載の容器入り水系組成物、[2]、[4]~[14]のいずれかに記載の水分蒸散抑制剤又は[3]、[4]~[14]のいずれかに記載の水分蒸散抑制方法。
[16]成分(B)を組成物全量に対して0.05~3質量%含有する[1]、[4]~[15]のいずれかに記載の容器入り水系組成物、[2]、[4]~[15]のいずれかに記載の水分蒸散抑制剤又は[3]、[4]~[15]のいずれかに記載の水分蒸散抑制方法。
[17]成分(C)ノニオン性界面活性剤のエチレンオキサイドの平均付加モル数が10以上である[1]、[4]~[15]のいずれかに記載の容器入り水系組成物、[2]、[4]~[15]のいずれかに記載の水分蒸散抑制剤、又は[3]、[4]~[15]のいずれかに記載の水分蒸散抑制方法。
[18]成分(C)ノニオン性界面活性剤のエチレンオキサイドの平均付加モル数が10~200である[1]、[4]~[16]のいずれかに記載の容器入り水系組成物、[2]、[4]~[16]のいずれかに記載の水分蒸散抑制剤、又は[3]、[4]~[16]のいずれかに記載の水分蒸散抑制方法。
[19]成分(C)が、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルキルフェニルエーテル、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油、ポリオキシアルキレン硬化ヒマシ油脂肪酸エステル及びポリオキシエチレンソルビトールから選ばれる1種又は2種以上である[1]、[4]~[18]のいずれかに記載の容器入り水系組成物、[2]、[4]~[18]のいずれかに記載の水分蒸散抑制剤、又は[3]、[4]~[18]のいずれかに記載の水分蒸散抑制方法。
[20]成分(C)が、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油及びポリオキシアルキレン硬化ヒマシ油脂肪酸エステルから選ばれる1種又は2種以上である[1]、[4]~[19]のいずれかに記載の容器入り水系組成物、[2]、[4]~[19]のいずれかに記載の水分蒸散抑制剤、又は[3]、[4]~[19]のいずれかに記載の水分蒸散抑制方法。
[21]成分(C)を組成物全量に対して0.001~15質量%含有する[1]、[4]~[20]のいずれかに記載の容器入り水系組成物、[2]、[4]~[20]のいずれかに記載の水分蒸散抑制剤、又は[3]、[4]~[20]のいずれかに記載の水分蒸散抑制方法。
[22]成分(C)を組成物全量に対して0.005~10質量%含有する[1]、[4]~[21]のいずれかに記載の容器入り水系組成物、[2]、[4]~[21]のいずれかに記載の水分蒸散抑制剤、又は[3]、[4]~[21]のいずれかに記載の水分蒸散抑制方法。
[23]成分(C)を組成物全量に対して0.01~5質量%含有する[1]、[4]~[22]のいずれかに記載の容器入り水系組成物、[2]、[4]~[22]のいずれかに記載の水分蒸散抑制剤、又は[3]、[4]~[22]のいずれかに記載の水分蒸散抑制方法。
[24]さらに多価アルコールを含有する[1]、[4]~[23]のいずれかに記載の容器入り水系組成物、[2]、[4]~[23]のいずれかに記載の水分蒸散抑制剤、又は[3]、[4]~[23]のいずれかに記載の水分蒸散抑制方法。
[25]さらに、(E)周期表1族の金属、周期表2族の金属、及びこれらの金属の水溶性化合物から選ばれる1種又は2種以上の化合物を含有する[1]、[4]~[24]のいずれかに記載の容器入り水系組成物、[2]、[4]~[24]のいずれかに記載の水分蒸散抑制剤、又は[3]、[4]~[24]のいずれかに記載の水分蒸散抑制方法。
[26]前記成分(E)が、ナトリウム、カリウム、マグネシウム、カルシウム、及びこれらの水溶性化合物から選ばれる1種又は2種以上である[25]記載の容器入り水系組成物、水分蒸散抑制剤又は水分蒸散抑制方法。
[27]形態が、水溶液、又は連続相が水相の乳化系である[1]、[4]~[26]のいずれかに記載の容器入り水系組成物。
[28]化粧料、医薬品、医薬部外品又は食品用水系組成物である[1]、[4]~[27]のいずれかに記載の容器入り水系組成物。
本発明における水相とは、水を含有する相である。
本発明の水系組成物は、製剤の安定性が保たれていれば、粘度(25℃)が100mPa・s以下の低粘度の液状であっても、高い水分蒸散抑制効果が得られる。
本発明の水系組成物の剤形は、水相が連続相であれば、特に制限されず、エマルション、ジェル状、スプレー状、ムース状等のものとすることができる。
下記表2に示す成分の試料1~14を開口面積13.85cm2のシャーレに5g添加し、湿度30%、温度30℃下で1、3、5、7、12、18、24時間経過後の試料の重量変化を測定した。その重量変化の傾きを最小二乗法により算出される(nX+m;Xは時間h)のnを水分蒸散速度(単位:mg/h)とし、絶対値としてプロットした。各試料計3回の平均値を求めた。尚、水分蒸散速度が小さいほど、蒸散を抑制したことになる。
下記表4及び5に示す成分の実施例1~5、比較例1~7及びコントロールを試験1と同様にして水分蒸散速度を測定した。また、コントロール(表5のコントロール)に対する水分蒸散抑制率を下記のように定義した。
A.成分(1)、(2)と成分(14)とを均一に混合する。
B.成分Aに成分(3)~(13)、(15)を徐々に加え、均一に混合する。
下記表6に示す実施例6~11、比較例8、9を、試験1及び2と同様の条件で試料の重量変化を測定し、水分蒸散速度、水分蒸散抑制率を求めた。
A.成分(1)と成分(6)とを均一に混合する。
B.成分Aに成分(2)~(5)、(7)、(8)を徐々に加え、均一に混合する。
Claims (17)
- 次の成分(A)~(D):
(A)アルキル基又はアルケニル基の炭素数が20~24で、エチレンオキサイドの平均付加モル数が1.5~4であるポリオキシエチレンアルキル又はアルケニルエーテル
(B)水溶性高分子
(C)エチレンオキサイド基を有するノニオン性界面活性剤(但し、(A)成分は除く)
(D)水
を含有する容器入り水系組成物。 - 成分(A)が、アルキル基又はアルケニル基の炭素数が20~24で、エチレンオキサイドの平均付加モル数1.5~3のポリオキシエチレンアルキル又はアルケニルエーテルである請求項1記載の容器入り組成物。
- 成分(A)を組成物全量に対して0.05~20質量%含有する請求項1又は2記載の容器入り水系組成物。
- 成分(B)が、カルボキシビニルポリマー、アクリル酸・メタクリル酸アルキル共重合体、キサンタンガム、ヒドロキシプロピルメチルセルロース、ポリアクリルアミド及び(アクリル酸Na/アクリロイルジメチルタウリンNa)コポリマーからなる群から選択される1種又は2種以上である請求項1~3のいずれかに記載の容器入り水系組成物。
- 成分(B)を組成物全量に対して0.01~5質量%含有する請求項1~4のいずれかに記載の容器入り水系組成物。
- 成分(C)ノニオン性界面活性剤のエチレンオキサイドの平均付加モル数が10以上である請求項1~5のいずれかに記載の容器入り水系組成物。
- 成分(C)ノニオン性界面活性剤のエチレンオキサイドの平均付加モル数が10~200である請求項1~6のいずれかに記載の容器入り水系組成物。
- 成分(C)が、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルキルフェニルエーテル、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油、ポリオキシアルキレン硬化ヒマシ油脂肪酸エステル及びポリオキシエチレンソルビトールから選ばれる1種又は2種以上である請求項1~7のいずれかに記載の容器入り水系組成物。
- 成分(C)が、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油及びポリオキシアルキレン硬化ヒマシ油脂肪酸エステルから選ばれる1種又は2種以上である請求項1~8のいずれかに記載の容器入り水系組成物。
- 成分(C)組成物全量に対して0.001~15質量%含有する請求項1~9のいずれかに記載の容器入り水系組成物。
- さらに多価アルコールを含有する請求項1~10のいずれかに記載の容器入り水系組成物。
- さらに、(E)周期表1族の金属、周期表2族の金属、及びこれらの金属の水溶性化合物から選ばれる1種又は2種以上の化合物を含有する請求項1~11のいずれかに記載の容器入り水系組成物。
- 前記成分(E)が、ナトリウム、カリウム、マグネシウム、カルシウム、及びこれらの水溶性化合物から選ばれる1種又は2種以上である請求項12記載の容器入り水系組成物。
- 形態が、水溶液、又は連続相が水相の乳化系である請求項1~13のいずれかに記載の容器入り水系組成物。
- 化粧料、医薬品、医薬部外品又は食品用水系組成物である請求項1~14のいずれかに記載の容器入り水系組成物。
- 次の成分(A)~(C):
(A)アルキル基又はアルケニル基の炭素数が20~24で、エチレンオキサイドの平均付加モル数が1.5~4であるポリオキシエチレンアルキル又はアルケニルエーテル
(B)水溶性高分子
(C)エチレンオキサイド基を有するノニオン性界面活性剤(但し、(A)成分は除く)を有効成分とする水系組成物からの水分蒸散抑制剤。 - 水系組成物中に、(A)アルキル基又はアルケニル基の炭素数が20~24で、エチレンオキサイドの平均付加モル数が1.5~4であるポリオキシエチレンアルキル又はアルケニルエーテル、(B)水溶性高分子、及び(C)エチレンオキサイド基を有するノニオン性界面活性剤(但し、(A)成分は除く)を含有させることを特徴とする水系組成物からの水分蒸散抑制方法。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020127030774A KR101536043B1 (ko) | 2010-05-27 | 2011-05-26 | 용기에 담긴 수계 조성물 |
US13/700,322 US8710066B2 (en) | 2010-05-27 | 2011-05-26 | Aqueous composition with agents to inhibit water evaporation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010121631A JP5581115B2 (ja) | 2010-05-27 | 2010-05-27 | 容器入り水系組成物 |
JP2010-121631 | 2010-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011149006A1 true WO2011149006A1 (ja) | 2011-12-01 |
Family
ID=45003992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2011/062062 WO2011149006A1 (ja) | 2010-05-27 | 2011-05-26 | 容器入り水系組成物 |
Country Status (5)
Country | Link |
---|---|
US (1) | US8710066B2 (ja) |
JP (1) | JP5581115B2 (ja) |
KR (1) | KR101536043B1 (ja) |
TW (1) | TWI483744B (ja) |
WO (1) | WO2011149006A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160025018A (ko) * | 2013-06-28 | 2016-03-07 | 스미또모 세이까 가부시키가이샤 | 친수성 증점제 및 화장료 조성물 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5584524B2 (ja) | 2010-06-07 | 2014-09-03 | 花王株式会社 | 水中油型乳化組成物及びその製造方法 |
US10100243B2 (en) | 2015-07-13 | 2018-10-16 | KMP Holdings, LLC | Environmentally preferable microemulsion composition |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3146059A (en) * | 1957-11-20 | 1964-08-25 | Nikken Chemicals Co Ltd | Evaporation-suppressing agents and method of their production |
JPS49121788A (ja) * | 1973-03-24 | 1974-11-21 | ||
JP2000265098A (ja) * | 1999-03-17 | 2000-09-26 | Fuji Xerox Co Ltd | 画像表示用記録液及び画像形成方法 |
JP2001181543A (ja) * | 1999-12-28 | 2001-07-03 | Asia Genshi Kk | 孔版印刷用エマルジョンインクおよびそれを用いる印刷方法 |
WO2004056216A1 (ja) * | 2002-12-19 | 2004-07-08 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 組成物における水分の変動を抑制する方法とその用途 |
JP2008081472A (ja) * | 2006-09-28 | 2008-04-10 | Kao Corp | 皮膚外用剤 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0620531B2 (ja) | 1988-04-20 | 1994-03-23 | 株式会社肌粧品科学開放研究所 | 乳化組成物 |
US7566460B2 (en) | 1995-06-22 | 2009-07-28 | 3M Innovative Properties Company | Stable hydroalcoholic compositions |
CA2224702C (en) | 1995-06-22 | 2013-01-08 | Robert A. Asmus | Stable hydroalcoholic compositions |
US6623744B2 (en) | 1995-06-22 | 2003-09-23 | 3M Innovative Properties Company | Stable hydroalcoholic compositions |
JP2003321321A (ja) | 2002-04-30 | 2003-11-11 | Lion Corp | 化粧料 |
US20060139426A1 (en) * | 2004-12-28 | 2006-06-29 | Fuji Xerox Co., Ltd. | Ink, ink set, processing solution, recording method, recording medium, ink tank, and recording device |
JP5689288B2 (ja) | 2010-05-17 | 2015-03-25 | 花王株式会社 | 皮膚外用剤 |
JP5695339B2 (ja) | 2010-04-27 | 2015-04-01 | 花王株式会社 | 容器入り水系組成物 |
JP5584524B2 (ja) | 2010-06-07 | 2014-09-03 | 花王株式会社 | 水中油型乳化組成物及びその製造方法 |
-
2010
- 2010-05-27 JP JP2010121631A patent/JP5581115B2/ja active Active
-
2011
- 2011-05-26 KR KR1020127030774A patent/KR101536043B1/ko active IP Right Grant
- 2011-05-26 WO PCT/JP2011/062062 patent/WO2011149006A1/ja active Application Filing
- 2011-05-26 TW TW100118517A patent/TWI483744B/zh not_active IP Right Cessation
- 2011-05-26 US US13/700,322 patent/US8710066B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3146059A (en) * | 1957-11-20 | 1964-08-25 | Nikken Chemicals Co Ltd | Evaporation-suppressing agents and method of their production |
JPS49121788A (ja) * | 1973-03-24 | 1974-11-21 | ||
JP2000265098A (ja) * | 1999-03-17 | 2000-09-26 | Fuji Xerox Co Ltd | 画像表示用記録液及び画像形成方法 |
JP2001181543A (ja) * | 1999-12-28 | 2001-07-03 | Asia Genshi Kk | 孔版印刷用エマルジョンインクおよびそれを用いる印刷方法 |
WO2004056216A1 (ja) * | 2002-12-19 | 2004-07-08 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 組成物における水分の変動を抑制する方法とその用途 |
JP2008081472A (ja) * | 2006-09-28 | 2008-04-10 | Kao Corp | 皮膚外用剤 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160025018A (ko) * | 2013-06-28 | 2016-03-07 | 스미또모 세이까 가부시키가이샤 | 친수성 증점제 및 화장료 조성물 |
EP3015525A4 (en) * | 2013-06-28 | 2016-11-02 | Sumitomo Seika Chemicals | HYDROPHILIC THICKENER AND COSMETIC COMPOSITION THEREWITH |
US9763869B2 (en) | 2013-06-28 | 2017-09-19 | Sumitomo Seika Chemicals Co., Ltd. | Hydrophilic thickener and cosmetic composition |
KR102166555B1 (ko) | 2013-06-28 | 2020-10-16 | 스미또모 세이까 가부시키가이샤 | 친수성 증점제 및 화장료 조성물 |
Also Published As
Publication number | Publication date |
---|---|
US20130096205A1 (en) | 2013-04-18 |
TWI483744B (zh) | 2015-05-11 |
JP2011246398A (ja) | 2011-12-08 |
TW201143812A (en) | 2011-12-16 |
KR20130109934A (ko) | 2013-10-08 |
JP5581115B2 (ja) | 2014-08-27 |
US8710066B2 (en) | 2014-04-29 |
KR101536043B1 (ko) | 2015-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5584524B2 (ja) | 水中油型乳化組成物及びその製造方法 | |
KR101443951B1 (ko) | 살균 청정제 조성물 | |
JP6125718B2 (ja) | デオドラント組成物及びデオドラント剤 | |
KR20130069542A (ko) | 용기에 담은 수계 조성물 | |
JP6830629B2 (ja) | 消毒用組成物 | |
JP5581115B2 (ja) | 容器入り水系組成物 | |
JP5695339B2 (ja) | 容器入り水系組成物 | |
JP2012246248A (ja) | 化粧料 | |
WO2014070689A1 (en) | Personal care compositions having a tan delta of 0.30 or more at 10°c | |
KR20170029619A (ko) | 액상 피부 외용제 | |
JP6118524B2 (ja) | 容器入り水系組成物 | |
JP6900121B2 (ja) | 制汗剤組成物、及び制汗剤 | |
JPH09157637A (ja) | エアゾール組成物 | |
WO2013136890A1 (ja) | 皮膚外用剤 | |
JP2016000704A (ja) | 体臭抑制剤 | |
JP7553274B2 (ja) | 殺菌消毒用エアゾール組成物 | |
WO2017080945A1 (en) | Anti-perspirant composition | |
JP2021187849A (ja) | ヒアルロニダーゼ活性阻害剤及びヒアルロニダーゼ活性の阻害効果の増強方法 | |
JP2022183421A (ja) | プロスタグランジンe2産生抑制皮膚外用剤 | |
JP2009190986A (ja) | 透明ジェル化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11786705 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 20127030774 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13700322 Country of ref document: US Ref document number: 1201006074 Country of ref document: TH |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11786705 Country of ref document: EP Kind code of ref document: A1 |